Expression of HBx protein in hepatitis B virusinfected intrahepatic cholangiocarcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 5, 2012, Pages 532-535

  Zhou, Yan Ming ^a   Cao, Lu ^b   Li, Bin ^a   Zhang, Xiu Zhong ^b   Yin, Zheng Feng ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HBx protein; Hepatitis B virus; Intrahepatic cholangiocarcinoma; p53

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B VIRUS X PROTEIN; PROTEIN P53;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER SIZE; CANCER STAGING; CANCER SURGERY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER CIRCULATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 84867828096     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60219-7     Document Type: Article

References (23)

1. Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am 2010;90:817-837.
2. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48:323-328.
3. Kanemitsu E, Esaki M. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis. Jpn J Clin Oncol 2010;40:600.
4. Hur H, Park IY, Sung GY, Lee DS, Kim W, Won JM. Intrahepatic cholangiocarcinoma associated with intrahepatic duct stones. Asian J Surg 2009;32:7-12.
5. Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008;14:632-635.
6. Tanaka M, Tanaka H, Tsukuma H, Ioka A, Oshima A, Nakahara T. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat 2010;17:742-748.
7. Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology 2011;53:1217-1225.
8. Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, et al. Distinctive gene expression profiles associated with Hepatitis B virus x protein. Oncogene 2001; 20:3674-3682.
9. Wang WL, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991;51:4971-4977.
10. Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD. p53 Mutations in human cholangiocarcinoma: a review. Liver Int 2005;25:704-716.
11. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996;88:1442-1455.
12. Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis. J Clin Virol 2005;34:S75-78.
13. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 1977;39:232-246.
14. Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, et al. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Am J Gastroenterol 1999;94:2128-2134.
15. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998;227:70-79.
16. Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 2007; 31:1059-1067.
17. Fujii T, Zen Y, Nakanuma Y. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma. J Gastroenterol 2007;42:698-702.
18. Alison MR. Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 2005;1:253-260.
19. Ishikawa K, Sasaki A, Haraguchi N, Yoshikawa Y, Mori M. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin. Oncologist 2007;12:320-324.
20. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999;154:537-541.
21. Xiao JC, Jin XL, Ruck P, Adam A, Kaiserling E. Hepatic progenitor cells in human liver cirrhosis: immunohistochemical, electron microscopic and immunofluorenscence confocal microscopic findings. World J Gastroenterol 2004;10:1208-1211.
22. Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F, Bianchi L. Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol 1992;15:400-403.
23. Batheja N, Suriawinata A, Saxena R, Ionescu G, Schwartz M, Thung SN. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Mod Pathol 2000;13:1265-1268.